{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:53:32Z","timestamp":1777442012949,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:00:00Z","timestamp":1473811200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/63746\/2009"],"award-info":[{"award-number":["SFRH\/BPD\/63746\/2009"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/110001\/2015"],"award-info":[{"award-number":["SFRH\/BPD\/110001\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/DTP-FTO\/1489\/2014"],"award-info":[{"award-number":["PTDC\/DTP-FTO\/1489\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00204-016-1839-z","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T06:23:39Z","timestamp":1473834219000},"page":"1871-1890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy"],"prefix":"10.1007","volume":"91","author":[{"given":"A.","family":"Reis-Mendes","sequence":"first","affiliation":[]},{"given":"A. S.","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"R. A.","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"F.","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"F.","family":"Remi\u00e3o","sequence":"additional","affiliation":[]},{"given":"M.","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"M. L.","family":"Bastos","sequence":"additional","affiliation":[]},{"given":"E.","family":"Sousa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0471-2756","authenticated-orcid":false,"given":"V. M.","family":"Costa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,9,14]]},"reference":[{"issue":"1","key":"1839_CR1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djp440","volume":"102","author":"A Albini","year":"2010","unstructured":"Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM (2010) Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst 102(1):14\u201325","journal-title":"J Natl Cancer Inst"},{"issue":"9972","key":"1839_CR2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","volume":"385","author":"C Allemani","year":"2015","unstructured":"Allemani C, Weir HK, Carreira H et al (2015) Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). The Lancet 385(9972):977\u20131010","journal-title":"The Lancet"},{"issue":"1","key":"1839_CR3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1191\/1352458503ms896oa","volume":"9","author":"JR Avasarala","year":"2003","unstructured":"Avasarala JR, Cross AH, Clifford DB, Singer BA, Siegel BA, Abbey EE (2003) Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis. Mult Scler 9(1):59\u201362","journal-title":"Mult Scler"},{"issue":"5","key":"1839_CR4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0090-9556(25)08964-0","volume":"19","author":"J Blanz","year":"1991","unstructured":"Blanz J, Mewes K, Ehninger G et al (1991) Evidence for oxidative activation of mitoxantrone in human, pig, and rat. Drug Metab Dispos 19(5):871\u2013880","journal-title":"Drug Metab Dispos"},{"key":"1839_CR46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.biochi.2010.09.015","volume":"93","author":"TB Bruck","year":"2011","unstructured":"Bruck TB, Bruck DW (2011) Oxidative metabolism of the anti-cancer agent mitoxantrone by horseradish, lacto-and lignin peroxidase. Biochimie 93:217\u2013226","journal-title":"Biochimie"},{"key":"1839_CR47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1570-9639(03)00168-7","volume":"1649","author":"TB Bruck","year":"2003","unstructured":"Bruck TB, Harvey PJ (2003) Oxidation of mitoxantrone by lactoperoxidase. Biochim Biophys Acta 1649:154\u2013163","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1839_CR5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.105.092577","volume":"316","author":"JP Capela","year":"2006","unstructured":"Capela JP, Meisel A, Abreu AR et al (2006) Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. J Pharmacol Exp Ther 316(1):53\u201361","journal-title":"J Pharmacol Exp Ther"},{"key":"1839_CR6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuro.2012.09.005","volume":"34","author":"JP Capela","year":"2013","unstructured":"Capela JP, da Costa Araujo S, Costa VM et al (2013) The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons. Neurotoxicology 34:254\u2013263","journal-title":"Neurotoxicology"},{"key":"1839_CR7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/9780470660379.ch5","volume-title":"Cardiotoxicity of non-cardiovascular drugs","author":"JR Carver","year":"2010","unstructured":"Carver JR, Desai CJ (2010) Cardiovascular toxicity of antitumor drugs: dimension of the problem in adult settings. In: Minotti G (ed) Cardiotoxicity of non-cardiovascular drugs. Wiley, Hoboken, pp 127\u2013199"},{"issue":"9","key":"1839_CR8","first-page":"4858","volume":"46","author":"FS Chiccarelli","year":"1986","unstructured":"Chiccarelli FS, Morrison JA, Cosulich DB et al (1986) Identification of human urinary mitoxantrone metabolites. Cancer Res 46(9):4858\u20134861","journal-title":"Cancer Res"},{"issue":"6","key":"1839_CR9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0277-5379(84)90215-3","volume":"20","author":"RE Coleman","year":"1984","unstructured":"Coleman RE, Maisey MN, Knight RK, Rubens RD (1984) Mitoxantrone in advanced breast cancer\u2014a phase II study with special attention to cardiotoxicity. Eur J Cancer Clin Oncol 20(6):771\u2013776","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"8","key":"1839_CR10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1021\/tx7000916","volume":"20","author":"VM Costa","year":"2007","unstructured":"Costa VM, Silva R, Ferreira LM et al (2007) Oxidation process of adrenaline in freshly isolated rat cardiomyocytes: formation of adrenochrome, quinoproteins, and GSH adduct. Chem Res Toxicol 20(8):1183\u20131191","journal-title":"Chem Res Toxicol"},{"issue":"1\u20132","key":"1839_CR11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tox.2008.12.010","volume":"257","author":"VM Costa","year":"2009","unstructured":"Costa VM, Silva R, Ferreira R et al (2009a) Adrenaline in pro-oxidant conditions elicits intracellular survival pathways in isolated rat cardiomyocytes. Toxicology 257(1\u20132):70\u201379","journal-title":"Toxicology"},{"issue":"1\u20133","key":"1839_CR12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tox.2009.03.012","volume":"260","author":"VM Costa","year":"2009","unstructured":"Costa VM, Silva R, Tavares LC et al (2009b) Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes. Toxicology 260(1\u20133):84\u201396","journal-title":"Toxicology"},{"issue":"18","key":"1839_CR13","first-page":"6100","volume":"50","author":"M Dietel","year":"1990","unstructured":"Dietel M, Arps H, Lage H, Niendorf A (1990) Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res 50(18):6100\u20136106","journal-title":"Cancer Res"},{"key":"1839_CR14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tox.2015.01.006","volume":"329","author":"JL Dores-Sousa","year":"2015","unstructured":"Dores-Sousa JL, Duarte JA, Seabra V, Bastos ML, Carvalho F, Costa VM (2015) The age factor for mitoxantrone\u2019s cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury. Toxicology 329:106\u2013119","journal-title":"Toxicology"},{"issue":"5","key":"1839_CR15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00003088-199018050-00003","volume":"18","author":"G Ehninger","year":"1990","unstructured":"Ehninger G, Schuler U, Proksch B, Zeller KP, Blanz J (1990) Pharmacokinetics and metabolism of mitoxantrone. A review. Clin Pharmacokinet 18(5):365\u2013380","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"1839_CR16","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1016\/S0006-3495(97)78357-7","volume":"73","author":"A Feofanov","year":"1997","unstructured":"Feofanov A, Sharonov S, Fleury F, Kudelina I, Nabiev I (1997a) Quantitative confocal spectral imaging analysis of mitoxantrone within living K562 cells: intracellular accumulation and distribution of monomers, aggregates, naphtoquinoxaline metabolite, and drug-target complexes. Biophys J 73(6):3328\u20133336","journal-title":"Biophys J"},{"issue":"6","key":"1839_CR17","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1016\/S0006-3495(97)78356-5","volume":"73","author":"A Feofanov","year":"1997","unstructured":"Feofanov A, Sharonov S, Kudelina I, Fleury F, Nabiev I (1997b) Localization and molecular interactions of mitoxantrone within living K562 cells as probed by confocal spectral imaging analysis. Biophys J 73(6):3317\u20133327","journal-title":"Biophys J"},{"issue":"6","key":"1839_CR18","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374\u20131403","journal-title":"Eur J Cancer"},{"issue":"2\u20133","key":"1839_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxlet.2012.11.015","volume":"216","author":"PS Ferreira","year":"2013","unstructured":"Ferreira PS, Nogueira TB, Costa VM et al (2013) Neurotoxicity of \u201cecstasy\u201d and its metabolites in human dopaminergic differentiated SH-SY5Y cells. Toxicol Lett 216(2\u20133):159\u2013170","journal-title":"Toxicol Lett"},{"issue":"2","key":"1839_CR20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.toxlet.2005.07.001","volume":"160","author":"G Fotakis","year":"2006","unstructured":"Fotakis G, Timbrell JA (2006) In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 160(2):171\u2013177","journal-title":"Toxicol Lett"},{"issue":"2","key":"1839_CR21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.toxlet.2013.03.007","volume":"219","author":"M Freitas","year":"2013","unstructured":"Freitas M, Costa VM, Ribeiro D et al (2013) Acetaminophen prevents oxidative burst and delays apoptosis in human neutrophils. Toxicol Lett 219(2):170\u2013177","journal-title":"Toxicol Lett"},{"issue":"8","key":"1839_CR22","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.4155\/bio.09.128","volume":"1","author":"SDB Goldman","year":"2009","unstructured":"Goldman SDB, Funk RS, Rajewski RA, Krise JP (2009) Mechanisms of amine accumulation in, and egress from, lysosomes. Bioanalysis 1(8):1445\u20131459","journal-title":"Bioanalysis"},{"issue":"5\u20136","key":"1839_CR23","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/ars.2006.8.1081","volume":"8","author":"MK Gupta","year":"2006","unstructured":"Gupta MK, Neelakantan TV, Sanghamitra M et al (2006) An assessment of the role of reactive oxygen species and redox signaling in norepinephrine-induced apoptosis and hypertrophy of H9c2 cardiac myoblasts. Antioxid Redox Signal 8(5\u20136):1081\u20131093","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"1839_CR24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-4827(76)90447-X","volume":"98","author":"BW Kimes","year":"1976","unstructured":"Kimes BW, Brandt BL (1976) Properties of a clonal muscle cell line from rat heart. Exp Cell Res 98(2):367\u2013381","journal-title":"Exp Cell Res"},{"issue":"42","key":"1839_CR25","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1038\/sj.onc.1207936","volume":"23","author":"J Kluza","year":"2004","unstructured":"Kluza J, Marchetti P, Gallego M-A et al (2004) Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene 23(42):7018\u20137030","journal-title":"Oncogene"},{"key":"1839_CR48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0891-5849(88)90058-5","volume":"5","author":"P Kolodziejczyk","year":"1988","unstructured":"Kolodziejczyk P, Reszka K, Lown JW (1988) Enzymatic oxidative activation and transformation of the antitumor agent mitoxantrone. Free Radic Biol Med 5:13\u201325","journal-title":"Free Radic Biol Med"},{"key":"1839_CR26","doi-asserted-by":"crossref","first-page":"347312","DOI":"10.1155\/2013\/347312","volume":"2013","author":"JB Martins","year":"2013","unstructured":"Martins JB, Bastos Mde L, Carvalho F, Capela JP (2013) Differential effects of methyl-4-phenylpyridinium ion, rotenone, and paraquat on differentiated SH-SY5Y cells. J Toxicol 2013:347312","journal-title":"J Toxicol"},{"issue":"5","key":"1839_CR27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1021\/tx800002r","volume":"21","author":"P Menna","year":"2008","unstructured":"Menna P, Salvatorelli E, Minotti G (2008) Cardiotoxicity of antitumor drugs. Chem Res Toxicol 21(5):978\u2013989","journal-title":"Chem Res Toxicol"},{"issue":"21","key":"1839_CR28","first-page":"5135","volume":"53","author":"K Mewes","year":"1993","unstructured":"Mewes K, Blanz J, Ehninger G, Gebhardt R, Zeller KP (1993) Cytochrome P-450-induced cytotoxicity of mitoxantrone by formation of electrophilic intermediates. Cancer Res 53(21):5135\u20135142","journal-title":"Cancer Res"},{"issue":"11","key":"1839_CR29","doi-asserted-by":"crossref","first-page":"e49366","DOI":"10.1371\/journal.pone.0049366","volume":"7","author":"RA Ndolo","year":"2012","unstructured":"Ndolo RA, Luan Y, Duan S, Forrest ML, Krise JP (2012) Lysosomotropic properties of weakly basic anticancer agents promote cancer cell selectivity in vitro. PLoS ONE 7(11):e49366","journal-title":"PLoS ONE"},{"issue":"12","key":"1839_CR30","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/0006-2952(94)00429-3","volume":"48","author":"C Panousis","year":"1994","unstructured":"Panousis C, Kettle AJ, Phillips DR (1994) Oxidative metabolism of mitoxantrone by the human neutrophil enzyme myeloperoxidase. Biochem Pharmacol 48(12):2223\u20132230","journal-title":"Biochem Pharmacol"},{"issue":"1\u20132","key":"1839_CR31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3835(97)04611-9","volume":"113","author":"C Panousis","year":"1997","unstructured":"Panousis C, Kettle AJ, Phillips DR (1997) Neutrophil-mediated activation of mitoxantrone to metabolites which form adducts with DNA. Cancer Lett 113(1\u20132):173\u2013178","journal-title":"Cancer Lett"},{"issue":"2","key":"1839_CR32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12012-011-9112-4","volume":"11","author":"SL Pereira","year":"2011","unstructured":"Pereira SL, Ramalho-Santos J, Branco AF, Sardao VA, Oliveira PJ, Carvalho RA (2011) Metabolic remodeling during H9c2 myoblast differentiation: relevance for in vitro toxicity studies. Cardiovasc Toxicol 11(2):180\u2013190","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"1839_CR33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00172015","volume":"4","author":"CB Pratt","year":"1986","unstructured":"Pratt CB, Vietti TJ, Etcubanas E et al (1986) Novantrone for childhood malignant solid tumors. A pediatric oncology group phase II study. Invest New Drugs 4(1):43\u201348","journal-title":"Invest New Drugs"},{"issue":"1","key":"1839_CR34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1389200216666151103114926","volume":"17","author":"A Reis-Mendes","year":"2015","unstructured":"Reis-Mendes A, Sousa E, Bastos ML, Costa VM (2015) Metabolism of anticancer drugs and cardiotoxicity: a missing link? Curr Drug Metab 17(1):75\u201390","journal-title":"Curr Drug Metab"},{"key":"1839_CR49","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0026-895X(25)09621-X","volume":"50","author":"KJ Reszka","year":"1996","unstructured":"Reszka KJ, Chignell CF (1996) Acid-catalyzed oxidation of the anticancer agent mitoxantrone by nitrite ions. Mol Pharmacol 50:1612\u20131618","journal-title":"Mol Pharmacol"},{"key":"1839_CR50","first-page":"25","volume":"2","author":"K Reszka","year":"1986","unstructured":"Reszka K, Kolodziejczyk P, Lown JW (1986) Horseradish peroxidase-catalyzed oxidation of mitoxantrone: spectrophotometric and electron paramagnetic resonance studies. J Free Radic Biol Med 2:25\u201332","journal-title":"J Free Radic Biol Med"},{"key":"1839_CR35","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00204-013-1040-6","volume":"87","author":"LG Rossato","year":"2013","unstructured":"Rossato LG, Costa VM, de Pinho PG et al (2013a) The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity. Arch Toxicol 87:1809\u20131820","journal-title":"Arch Toxicol"},{"issue":"4","key":"1839_CR36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12012-013-9224-0","volume":"13","author":"LG Rossato","year":"2013","unstructured":"Rossato LG, Costa VM, Vilas-Boas V et al (2013b) Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event. Cardiovasc Toxicol 13(4):413\u2013425","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"1839_CR37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12012-013-9230-2","volume":"14","author":"LG Rossato","year":"2014","unstructured":"Rossato LG, Costa V, Dallegrave E et al (2014) Mitochondrial cumulative damage induced by mitoxantrone: late onset cardiac energetic impairment. Cardiovasc Toxicol 14(1):30\u201340","journal-title":"Cardiovasc Toxicol"},{"issue":"10","key":"1839_CR38","doi-asserted-by":"crossref","first-page":"e46753","DOI":"10.1371\/journal.pone.0046753","volume":"7","author":"M Ruiz","year":"2012","unstructured":"Ruiz M, Courilleau D, Jullian JC et al (2012) A cardiac-specific robotized cellular assay identified families of human ligands as inducers of PGC-1alpha expression and mitochondrial biogenesis. PLoS ONE 7(10):e46753","journal-title":"PLoS ONE"},{"issue":"2","key":"1839_CR39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/14740338.4.2.219","volume":"4","author":"K Seiter","year":"2005","unstructured":"Seiter K (2005) Toxicity of the topoisomerase II inhibitors. Expert Opin Drug Saf 4(2):219\u2013234","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"1839_CR40","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.bcp.2008.01.021","volume":"75","author":"J Shi","year":"2008","unstructured":"Shi J, Shen HM (2008) Critical role of Bid and Bax in indirubin-3\u2032-monoxime-induced apoptosis in human cancer cells. Biochem Pharmacol 75(9):1729\u20131742","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1839_CR41","first-page":"550","volume":"53","author":"NG Shipp","year":"1993","unstructured":"Shipp NG, Dorr RT, Alberts DS, Dawson BV, Hendrix M (1993) Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells. Cancer Res 53(3):550\u2013556","journal-title":"Cancer Res"},{"issue":"14","key":"1839_CR42","first-page":"4000","volume":"52","author":"PJ Smith","year":"1992","unstructured":"Smith PJ, Sykes HR, Fox ME, Furlong IJ (1992) Subcellular distribution of the anticancer drug mitoxantrone in human and drug-resistant murine cells analyzed by flow cytometry and confocal microscopy and its relationship to the induction of DNA damage. Cancer Res 52(14):4000\u20134008","journal-title":"Cancer Res"},{"issue":"8","key":"1839_CR43","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.biopha.2013.08.003","volume":"67","author":"AS Soares","year":"2013","unstructured":"Soares AS, Costa VM, Diniz C, Fresco P (2013) Potentiation of cytotoxicity of paclitaxel in combination with Cl-IB-MECA in human C32 metastatic melanoma cells: a new possible therapeutic strategy for melanoma. Biomed Pharmacother 67(8):777\u2013789","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1839_CR44","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00432-014-1645-z","volume":"140","author":"AS Soares","year":"2014","unstructured":"Soares AS, Costa VM, Diniz C, Fresco P (2014) Combination of Cl-IB-MECA with paclitaxel is a highly effective cytotoxic therapy causing mTOR-dependent autophagy and mitotic catastrophe on human melanoma cells. J Cancer Res Clin Oncol 140(6):921\u2013935","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"1839_CR45","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.18632\/oncotarget.2732","volume":"6","author":"B Zhitomirsky","year":"2015","unstructured":"Zhitomirsky B, Assaraf YG (2015) Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance. Oncotarget 6(2):1143\u20131156","journal-title":"Oncotarget"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-016-1839-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-016-1839-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-016-1839-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:37:35Z","timestamp":1749580655000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-016-1839-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,14]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1839"],"URL":"https:\/\/doi.org\/10.1007\/s00204-016-1839-z","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,14]]}}}